Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Merck Appoints Heads For US And China

This article was originally published in Scrip

Executive Summary

Merck (of Germany) has appointed Gary Zieziula president and managing director of the company's biopharma business in US and Canada and Marc Horn will lead the biopharma business in China as managing director. Zieziula joined Merck in 2014 as chief commercial officer in the US and has previously held senior level positions at Bristol Myers-Squibb, Roche and Amag Pharmaceuticals. Currently Horn is the regional chief financial officer (CFO) of Merck responsible for Eastern Asia for Healthcare, Life Science and Performance Materials. He has over 16 years' finance experience in the pharma and chemicals industry and has held positions at Bayer and Lanxess.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

SC064326

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst

Cancel